BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18462298)

  • 1. Urticarial vasculitis due do infliximab.
    Goulão J; Cunha H; Anes I; Bártolo E; Furtado C; Serrano P; Brandão FM
    J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):882-3. PubMed ID: 18462298
    [No Abstract]   [Full Text] [Related]  

  • 2. Enalapril induced normocomplementemic urticarial vasculitis.
    Koregol S; Naidu V; Rao S; Ankad BS
    Indian J Dermatol Venereol Leprol; 2015; 81(1):73-4. PubMed ID: 25566910
    [No Abstract]   [Full Text] [Related]  

  • 3. Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris.
    de Groot M; de Rie MA; Bos JD
    Br J Dermatol; 2005 Oct; 153(4):843-4. PubMed ID: 16181475
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum sickness due to infliximab in a patient with psoriasis.
    Krishnan RS; Hsu S
    J Drugs Dermatol; 2004; 3(3):305-8. PubMed ID: 15176166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of bullous pemphigoid during treatment of psoriasis with adalimumab.
    Stausbøl-Grøn B; Deleuran M; Sommer Hansen E; Kragballe K
    Clin Exp Dermatol; 2009 Oct; 34(7):e285-6. PubMed ID: 19438555
    [No Abstract]   [Full Text] [Related]  

  • 6. Prospective study of urticaria after diphencyprone therapy in patients with viral warts.
    Choi JE; Seo SH; Kim IH; Son SW
    Int J Dermatol; 2007 Dec; 46(12):1313-4. PubMed ID: 18173535
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab-induced eczematid-like purpura of Doucas and Kapetenakis.
    Wang LC; Medenica MM; Shea CR; Busbey S
    J Am Acad Dermatol; 2003 Jul; 49(1):157-8. PubMed ID: 12833033
    [No Abstract]   [Full Text] [Related]  

  • 8. Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome.
    Polat AK; Belli AA; Karakus V; Dere Y
    An Bras Dermatol; 2017; 92(5 Suppl 1):59-61. PubMed ID: 29267448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed maculopapular, urticarial rash due to infliximab in two children with systemic onset juvenile idiopathic arthritis.
    Tutar E; Ekici F; Naçar N; Arici S; Atalay S
    Rheumatology (Oxford); 2004 May; 43(5):674-5. PubMed ID: 15103034
    [No Abstract]   [Full Text] [Related]  

  • 10. Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab.
    Vestergaard C; Deleuran M; Kragballe K
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1272-4. PubMed ID: 17894730
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastric MALT lymphoma in a patient receiving infliximab for psoriasis.
    Girard C; Guillot B; Bessis D
    Br J Dermatol; 2008 Aug; 159(2):497-8. PubMed ID: 18547313
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of infliximab in the treatment of psoriasis.
    Lee MR; Cooper AJ
    Australas J Dermatol; 2004 Aug; 45(3):193-5. PubMed ID: 15250904
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of primary varicella infection during infliximab treatment for psoriasis.
    Balato N; Gaudiello F; Balato A; Ayala F
    J Am Acad Dermatol; 2009 Apr; 60(4):709-10. PubMed ID: 19293027
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe neutrophilia induced by infliximab for psoriasis.
    de Oliveira JP; Levy A; Morel P; Guibal F
    Br J Dermatol; 2008 Jan; 158(1):200-1. PubMed ID: 18028489
    [No Abstract]   [Full Text] [Related]  

  • 15. Eczematous eruption in patients with psoriasis during risankizumab treatment.
    Kromer C; Schön MP; Mössner R
    Eur J Dermatol; 2020 Oct; 30(5):599-601. PubMed ID: 33185530
    [No Abstract]   [Full Text] [Related]  

  • 16. Urticarial vasculitis induced by fluoxetine.
    Roger D; Rollé F; Mausset J; Lavignac C; Bonnetblanc JM
    Dermatology; 1995; 191(2):164. PubMed ID: 8520068
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis.
    Diluvio L; Romiti ML; Angelini F; Campione E; Rossi P; Prinz JC; Chimenti S; Lamioni A
    Br J Dermatol; 2010 Apr; 162(4):895-7. PubMed ID: 20199542
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of generalized psoriasiform and pustular eruption induced by infliximab: evidence for skin-homing Th17 in the pathogenesis.
    Teraki Y; Tanaka S; Hitomi K; Izaki S
    Br J Dermatol; 2010 Dec; 163(6):1347-51. PubMed ID: 20731653
    [No Abstract]   [Full Text] [Related]  

  • 19. Erythema gyratum repens-like eruption occuring in resolving psoriasis during methotrexate therapy.
    Singal A; Sonthalia S; Pandhi D
    Int J Dermatol; 2010 Mar; 49(3):306-7. PubMed ID: 20465670
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal fulminant legionnaires' disease in a patient with severe erythodermic psoriasis treated with infliximab after long-term steroid therapy.
    Eisendle K; Fritsch P
    Br J Dermatol; 2005 Mar; 152(3):585-6. PubMed ID: 15787843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.